GlassScriptPhysician profile
Bryan Penalosa
NPI 1972035376
$4,450.25
in general payments reported to CMS, 2019-2025
7 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $1,927 · 2024: $1,944 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,491 · Food and Beverage: $1,729 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,491.01 |
| Food and Beverage | $1,729.46 |
| Education | $103.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,981.45 | 2023-2025 | Ri Hip Navigation, Journey, Or3o Dual Mobility |
| Stryker Corporation | $258.96 | 2022-2024 | T2 Alpha, Ortholoc 3di, Osteoset |
| Zimmer Biomet Holdings, INC. | $132.89 | 2025 | Persona, Rosa |
| Davol INC. | $24.84 | 2023 | Arista Ah Flexitip |
| Amgen INC. | $20.04 | 2025 | Evenity |
| Hydrocision, INC. | $18.97 | 2025 | Tenjet |
| W. L. Gore & Associates, INC. | $13.10 | 2023 | Gore Viabahn Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Penalosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.